The '2025 K-STAR Symposium" co-hosted by Korea University Anam Hospital Rosetta Hall Women's Heart Center and the National ...
Ultimately, investigators found a significant reduction in ischemic stroke risk with asundexian compared to placebo, both in combination with antiplatelet therapy. Additionally, participants had no ...
Diabetes, obesity, and cardiovascular issues are interconnected, impacting millions in India. Meril and The Times of India's ...
Stroke and heart attack are life-threatening conditions that require emergency medical attention, but they differ in the affected organ and symptoms.
The study reveals that widely used heart-attack risk calculators fail to flag nearly half of those who will soon experience a ...
Asundexian (Bayer) significantly reduces the risk of ischemic stroke compared with placebo, without increasing the risk of ...